Clinical Trial Update: Capecitabine or Observation for Patients With pT1N+M0 or pT2-3N0M0 Gastric Adenocarcinoma Undergoing R0 Resection [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating capecitabine versus observation after R0 resection in certain gastric cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Capecitabine (capecitabine)

Snippet

Sponsor: The First Affiliated Hospital of Anhui Medical University | Conditions: Gastric Cancer | Phase 3 | Status: UNKNOWN